Portable molecular diagnostic instruments in microbiology: current status

Clinical Microbiology and Infection

Volumn 26, Issue 4, 2020, Pages 411-420

  Zidovec Lepej, S ^a   Poljak, M ^b  

^a Croatia   (Croatia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Isothermal nucleic acid amplification; Mobile microbiology; Molecular diagnostics; Polymerase chain reaction; Portable instruments

Indexed keywords

VIRUS RNA;

EMERGENCY CARE; HEALTH CARE QUALITY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY; MICROBIOLOGY; MICROORGANISM DETECTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; DEVICES; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; POINT OF CARE SYSTEM; POLYMERASE CHAIN REACTION; PROCEDURES; SENSITIVITY AND SPECIFICITY;

HUMANS; LABORATORIES; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 85073725267     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2019.09.017     Document Type: Review

References (66)

1. Weidmann, M., Faye, O., Faye, O., Abd El Wahed, A., Patel, P., Batejat, C., et al. Development of mobile laboratory for viral hemorrhagic fever detection in Africa. J Infect Dis 218 (2018), 1622–1630.
2. Inglis, T.J., Adapting the mobile laboratory to the changing needs of the Ebola virus epidemic. J Med Microbiol 64 (2015), 587–591.
3. IEA. Energy access outlook 2017. Available at: https://www.iea.org/access2017/.
4. Albert, H., Alavadi, U., Providing uninterrupted power for GeneXpert in low and middle income settings: a practical guide. Available at: https://www.finddx.org/wp-content/uploads/2018/02/UPS-guide-XpertMTB-RIF_FINAL_07DEC16.pdf.
5. Morokuma, N., Chiu, C.H., Trends and characteristics of security incidents involving aid workers in health care settings: a 20-year review. Prehosp Disaster Med 34 (2019), 265–273.
6. Abbott, Alere™ Q analyser. Available at: https://www.alere.com/en/home/product-details/alere-q-analyser.html.
7. UNAIDS data 2018. Available at: https://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf.
8. UNAIDS, Ending AIDS, toward the 90-90-90 targets. Available at: https://www.unaids.org/en/resources/documents/2017/20170720_Global_AIDS_update_2017, 2017.
9. Technau, K.G., Strehlau, R., Patel, F., Shiau, S., Burke, M., Conradie, M., et al. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study. Lancet HIV 5 (2018), e706–e714.
10. Kalk, E., Kroon, M., Boulle, A., Osler, M., Euvrard, J., Stinson, K., et al. Neonatal and infant diagnostic HIV-PCR uptake and associations during three sequential policy periods in Cape Town, South Africa: a longitudinal analysis. J Int AIDS Soc, 21, 2018, e25212.
11. Hsiao, N.Y., Dunning, L., Kroon, M., Myer, L., Laboratory evaluation of the Alere q point-of-care system for early infant HIV diagnosis. PLoS One, 11, 2016, e0152672.
12. Dunning, L., Kroon, M., Hsiao, N.-Y., Myer, L., Field evaluation of HIV point-of-care testing for early infant diagnosis in Cape Town, South Africa. PLoS One, 12, 2017, e0189226.
13. Meggi, B., Vojnov, L., Mabunda, N., Vubil, A., Zitha, A., Tobaiwa, O., et al. Performance of point-of-care birth HIV testing in primary health care clinics: an observational cohort study. PLoS One, 13, 2018, e0198344.
14. Sandbulte, M.R., Gautney, B.J., Maloba, M., Wexler, C., Brown, M., Mabachi, N., et al. Infant HIV testing at birth using point-of-care and conventional HIV DNA PCR: an implementation feasibility pilot study in Kenya. Pilot Feasibility Stud, 5, 2019, 18.
15. Cepheid, GeneXpert® Edge. Available at: http://www.cepheid.com/en/cepheid-solutions/systems/genexpert-systems/genexpert-edge.
16. Xpert Omni factsheet. Available at: https://www.ghdonline.org/uploads/OMNI_FACTSHEET_26012018_FINAL_qyHzL8O.pdf.
17. Chakravorty, S., Simmons, A.M., Rowneki, M., Parmar, H., Cao, Y., Ryan, J., et al. The New Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. Mbio, 8, 2017 pii: e00812-e00817.
18. Cepheid launches “GeneXpert Edge” test for MTB, reveals its Make in India plans. Available at: https://www.biovoicenews.com/cepheid-launches-genexpert-edge-test-for-mtb-reveals-its-make-in-india-plans/.
19. TB-Speed international training. Available at: https://www.tb-speed.com/actualite/tb-speed-international-training/.
20. Llibre, A., Shimakawa, Y., Mottez, E., Ainsworth, S., Buivan, T.P., Firth, R., et al. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut 67 (2018), 2017–2024.
21. Llibre, A., Shimakawa, Y., Duffy, D., Potential utility of the Genedrive point-of-care test for HCV RNA detection. Gut, 2018 pii: gutjnl-2018-317218.
22. Lemoine, M., Tillmann, H.L., What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut 67 (2018), 1916–1917.
23. Ivanova Reipold, E., Easterbrook, P., Trianni, A., Panneer, N., Krakower, D., Ongarello, S., et al. Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile. BMC Infect Dis, 17, 2017, 707.
24. WMD detector selector. Available at: https://www.wmddetectorselector.army.mil/detectorPages/35.aspx.
25. Basha, I.H.K., Ho, E.T.W., Yousuff, C.M., Hamid, N.H.B., Towards multiplex molecular diagnosis: a review of microfluidic genomic technologies. Micromachines (Basel), 8, 2017 pii: E266.
26. Micronics PanNAT STEC test and system receive FDA clearance. Available at: https://www.sony.com/en_us/SCA/company-news/press-releases/sony-corporation-of-america/2018/micronics-pannat-stec-test-and-system-receive-fda-clearance.html.
27. Bissonnette, L., Bergeron, M.G., The GenePOC Platform, a rational solution for extreme point-of-care testing. Micromachines (Basel), 7, 2016 pii: E94.
28. Revogene. Available at: https://www.genepoc-diagnostics.com/instrument/.
29. Genepoc obtains FDA clearance for its Genepoc™ carba test in the USA. Available at: https://www.genepoc-diagnostics.com/uncategorized/genepoc-obtains-fda-clearance-for-its-genepoc-carba-test-in-the-usa/.
30. Lab-quality results at the point of care. Available at: https://www.cobasliat.com/.
31. Binnicker, M.J., Espy, M.J., Irish, C.L., Vetter, E.A., Direct detection of influenza A and B viruses in less than 20 minutes using a commercially available rapid PCR assay. J Clin Microbiol 53 (2015), 2353–2354.
32. Chen, L., Tian, Y., Chen, S., Liesenfeld, O., Performance of the cobas Influenza A/B assay for rapid PCR-based detection of influenza compared to Prodesse ProFlu+ and viral culture. Eur J Microbiol Immunol 5 (2015), 236–245.
33. Nolte, F.S., Gauld, L., Barrett, S.B., Direct comparison of Alere i and cobas Liat Influenza A and B tests for rapid detection of influenza virus infection. J Clin Microbiol 54 (2016), 2763–2766.
34. Young, S., Illescas, P., Nicasio, J., Sickler, J.J., Diagnostic accuracy of the real-time PCR cobas Liat Influenza A/B assay and the Alere i Influenza A&B NEAR isothermal nucleic acid amplification assay for the detection of influenza using adult nasopharyngeal specimens. J Clin Virol 94 (2017), 86–90.
35. Melchers, W.J.G., Kuijpers, J., Sickler, J.J., Rahamat-Langendoen, J., Lab-in-a-tube: real-time molecular point-of-care diagnostics for influenza A and B using the cobas Liat system. J Med Virol 89 (2017), 1382–1386.
36. Valentin, T., Kieslinger, P., Stelzl, E., Santner, B.I., Groselj-Strele, A., Kessler, H.H., et al. Prospective evaluation of three rapid molecular tests for seasonal influenza in patients presenting at an emergency unit. J Clin Virol 111 (2019), 29–32.
37. Youngs, J., Iqbal, Y., Glass, S., Riley, P., Pope, C., Planche, T., et al. Implementation of the cobas Liat Influenza point-of-care test into an emergency department during a high-incidence season: a retrospective evaluation following real-world implementation. J Hosp Infect 101 (2019), 285–288.
38. Akashi, Y., Suzuki, H., Ueda, A., Hirose, Y., Hayashi, D., Imai, H., et al. Analytical and clinical evaluation of a point-of-care molecular diagnostic system and its influenza A/B assay for rapid molecular detection of the influenza virus. J Infect Chemother, 2019 pii: S1341-321X(19)30064-30069.
39. Maignan, M., Viglino, D., Hablot, M., Termoz Masson, N., Lebeugle, A., Collomb Muret, R., et al. Diagnostic accuracy of a rapid RT-PCR assay for point-of-care detection of influenza A/B virus at emergency department admission: a prospective evaluation during the 2017/2018 influenza season. PLoS One, 14, 2019, e0216308.
40. Gibson, J., Schechter-Perkins, E.M., Mitchell, P., Mace, S., Tian, Y., Williams, K., et al. Multi-center evaluation of the cobas Liat Influenza A/B & RSV assay for rapid point of care diagnosis. J Clin Virol 95 (2017), 5–9.
41. Ling, L., Kaplan, S.E., Lopez, J.C., Stiles, J., Lu, X., Tang, Y.W., Parallel validation of three molecular devices for simultaneous detection and identification of influenza A and B and respiratory syncytial viruses. J Clin Microbiol, 56, 2018 pii: e01691-17.
42. Banerjee, D., Kanwar, N., Hassan, F., Essmyer, C., Selvarangan, R., Comparison of six sample-to-answer influenza A/B and respiratory syncytial virus nucleic acid amplification assays using respiratory specimens from children. J Clin Microbiol, 56, 2018 pii: e00930-18.
43. Gosert, R., Naegele, K., Hirsch, H.H., Comparing the cobas Liat Influenza A/B and respiratory syncytial virus assay with multiplex nucleic acid testing. J Med Virol 91 (2019), 582–587.
44. Wang, F., Tian, Y., Chen, L., Luo, R., Sickler, J., Liesenfeld, O., et al. Accurate detection of Streptococcus pyogenes at the point of care using the cobas Liat Strep A nucleic acid test. Clin Pediatr (Phila) 56 (2017), 1128–1134.
45. Donato, L.J., Myhre, N.K., Murray, M.A., McDonah, M.R., Myers, J.F., Maxson, J.A., et al. Assessment of test performance and potential for environmental contamination associated with a point-of-care molecular assay for group A Streptococcus in an end user setting. J Clin Microbiol, 57, 2019 pii: e01629-18.
46. Rao, A., Berg, B., Quezada, T., Fader, R., Walker, K., Tang, S., et al. Diagnosis and antibiotic treatment of group a streptococcal pharyngitis in children in a primary care setting: impact of point-of-care polymerase chain reaction. BMC Pediatr, 19, 2019, 24.
47. Garg, S.K., Lu, K., Duncan, J., Peterson, L.R., Liesenfeld, O., Equivalent performance of the cobas Cdiff Test for use on the cobas Liat system and the cobas 4800 system. Eur J Microbiol Immunol (Bp) 7 (2017), 310–318.
48. Granato, P.A., Hansen, G., Herding, E., Chaudhuri, S., Tang, S., Garg, S.K., et al. Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection. PLoS One, 13, 2018, e0200498.
49. Hetem, D.J., Bos-Sanders, I., Nijhuis, R.H.T., Tamminga, S., Berlinger, L., Kuijper, E.J., et al. Evaluation of the Liat Cdiff assay for direct detection of Clostridioides difficile toxin genes within 20 minutes. J Clin Microbiol, 57, 2019 pii: e00416-e00419.
50. ID NOW™. Available at: https://www.alere.com/en/home/product-details/id-now.html.
51. Nie, S., Roth, R.B., Stiles, J., Mikhlina, A., Lu, X., Tang, Y.W., et al. Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol 52 (2014), 3339–3344.
52. Bell, J.J., Selvarangan, R., Evaluation of the Alere I influenza A&B nucleic acid amplification test by use of respiratory specimens collected in viral transport medium. J Clin Microbiol 52 (2014), 3992–3995.
53. Jokela, P., Vuorinen, T., Waris, M., Manninen, R., Performance of the Alere i influenza A&B assay and mariPOC test for the rapid detection of influenza A and B viruses. J Clin Virol 70 (2015), 72–77.
54. Hurtado, J.C., Mosquera, M.M., de Lazzari, E., Martínez, E., Torner, N., Isanta, R., et al. Evaluation of a new, rapid, simple test for the detection of influenza virus. BMC Infect Dis, 15, 2015, 44.
55. Hazelton, B., Gray, T., Ho, J., Ratnamohan, V.M., Dwyer, D.E., Kok, J., Detection of influenza A and B with the Alere i Influenza A & B: a novel isothermal nucleic acid amplification assay. Influenza Other Respir Virus. 9 (2015), 151–154.
56. Nguyen Van, J.C., Caméléna, F., Dahoun, M., Pilmis, B., Mizrahi, A., Lourtet, J., et al. Prospective evaluation of the Alere i Influenza A&B nucleic acid amplification versus Xpert Flu/RSV. Diagn Microbiol Infect Dis 85 (2016), 19–22.
57. Davis, S., Allen, A.J., O'Leary, R., Power, M., Price, D.A., Simpson, A.J., et al. Diagnostic accuracy and cost analysis of the Alere i Influenza A&B near-patient test using throat swabs. J Hosp Infect 97 (2017), 301–309.
58. Busson, L., Mahadeb, B., De Foor, M., Vandenberg, O., Hallin, M., Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza. Diagn Microbiol Infect Dis 87 (2017), 238–242.
59. Hassan, F., Crawford, J., Bonner, A.B., Ledeboer, N.A., Selvarangan, R., Multicenter evaluation of the Alere i influenza A&B assay using respiratory specimens collected in viral transport media. Diagn Microbiol Infect Dis 92 (2018), 294–298.
60. Trabattoni, E., Le, V., Pilmis, B., Pean de Ponfilly, G., Caisso, C., Couzigou, C., et al. Implementation of Alere i influenza A&B point of care test for the diagnosis of influenza in an ED. Am J Emerg Med 36 (2018), 916–921.
61. Peters, R.M., Schnee, S.V., Tabatabai, J., Schnitzler, P., Pfeil, J., Evaluation of Alere i RSV for rapid detection of respiratory syncytial virus in children hospitalized with acute respiratory tract infection. J Clin Microbiol 55 (2017), 1032–1036.
62. Schnee, S.V., Pfeil, J., Ihling, C.M., Tabatabai, J., Schnitzler, P., Performance of the Alere i RSV assay for point-of-care detection of respiratory syncytial virus in children. BMC Infect Dis, 17, 2017, 767.
63. Hassan, F., Hays, L.M., Bonner, A., Bradford, B.J., Franklin, R. Jr., Hendry, P., et al. Multicenter clinical evaluation of the Alere i respiratory syncytial virus isothermal nucleic acid amplification assay. J Clin Microbiol, 56, 2018 pii: e01777-17.
64. Cohen, D.M., Russo, M.E., Jaggi, P., Kline, J., Gluckman, W., Parekh, A., Multicenter clinical evaluation of the novel Alere i Strep A isothermal nucleic acid amplification test. J Clin Microbiol 53 (2015), 2258–2261.
65. Berry, G.J., Miller, C.R., Prats, M.M., Marquez, C., Oladipo, O.O., Loeffelholz, M.J., et al. Comparison of the Alere i Strep A test and the BD Veritor system in the detection of group A Streptococcus and the hypothetical impact of results on antibiotic utilization. J Clin Microbiol, 56, 2018 pii: e01310-e01317.
66. Weinzierl, E.P., Jerris, R.C., Gonzalez, M.D., Piccini, J.A., Rogers, B.B., Comparison of Alere i Strep A rapid molecular assay with rapid antigen testing and culture in a pediatric outpatient setting. Am J Clin Pathol, 2018 Epub ahead of print.